89020 Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 

other than their time. The total estimated annualized burden hours are 

2,000. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

Individuals (standard DUC form) ..................................................................... 1,800 1 1 1,800 

Individuals (additional AI/AN DUC form when needed) .................................. 200 1 1 200 

Total .......................................................................................................... ...................... 2,000 ........................ 2,000 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2024–26138 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Fogarty International 

Center Advisory Board. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. 

Individuals who plan to attend inperson or view the virtual meeting and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session can be accessed from the 

Fogarty International Center website 

(https://www.fic.nih.gov/About/ 

Advisory/Pages/default.aspx). 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: February 10–11, 2025. 

Closed: February 10, 2025, 1:00 p.m. to 

4:00 p.m. 

Agenda: To review and evaluate the 

second level of grant applications. 

Address: Fogarty International Center, 

National Institutes of Health, Lawton Chiles 

International House (Stone House), 16 Center 

Drive, Conference Room, Bethesda, MD 

20892 (In-person and Virtual Meeting). 

Open: February 11, 2025, 9:00 a.m. to 3:00 

p.m. 

Agenda: Update and discussion of current 

and planned Fogarty International Center 

activities. 

Address: Fogarty International Center, 

National Institutes of Health, Lawton Chiles 

International House (Stone House), 16 Center 

Drive, Conference Room, Bethesda, MD 

20892 (In-person and Virtual Meeting). 

Meeting Access: https://www.fic.nih.gov/ 

About/Advisory/Pages/default.aspx. 

Contact Person: Kristen Weymouth, 

Executive Secretary, Fogarty International 

Center, 31 Center Drive, Room B2C02, 

Bethesda, MD 20892, 301–495–1415, 

kristen.weymouth@nih.gov. 

Any interested person may file written 

comments with the committee by 

forwarding the statement to the Contact 

Persons listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/ 

about-nih/visitor-information/ 

campusaccess-security for entrance into 

on-campus and off-campus facilities. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal 

facility will be asked to show one form 

of identification (for example, a 

government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.fic.nih.gov/About/Advisory/Pages/ 

default.aspx, where an agenda and any 

additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 

Awards Program, National Institutes of 

Health, HHS) 

Dated: November 5, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26112 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Diabetes and 

Digestive and Kidney Diseases Advisory 

Council. 

Date: January 29–30, 2025. 

Open: January 29, 2025, 8:30 a.m. to 12:00 

p.m. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 218 / Tuesday, November 12, 2024 / Notices 89021 

Agenda: Call to order; Announcements; 

Consideration of Summary Minutes for May 

2024 Council, Future Council Dates; Report 

from the Director; Speakers; Concept 

Clearance. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conference 

Room, 31 Center Drive, Bethesda, MD 20892 

(In-Person and Virtual Meeting). 

Open: January 29, 2025, 1:00 p.m. to 2:30 

p.m. 

Agenda: KUH Open session. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

B (KUH), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Open: January 29, 2025, 1:00 p.m. to 2:15 

p.m. 

Agenda: DEM Open session. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

F&G (DEM), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Open: January 29, 2025, 1:00 p.m. to 2:30 

p.m. 

Agenda: DDN Open session. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

A (DDN), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Closed: January 29, 2025, 2:15 p.m. to 3:30 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

A (DDN), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Closed: January 29, 2025, 2:15 p.m. to 3:30 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

B (KUH), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Closed: January 29, 2025, 2:15 p.m. to 3:30 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

F&G (DEM), 31 Center Drive, Bethesda, MD 

20892 (In-Person and Virtual Meeting). 

Closed: January 29, 2025, 3:45 p.m. to 4:00 

p.m. 

Agenda: Reports of Subcommittees and 

Consideration of Applications. 

Address: National Institutes of Health, 

Building 31, C Wing 6th Floor Conf. Room 

F&G, 31 Center Drive, Bethesda, MD 20892 

(In-Person and Virtual Meeting). 

Contact Person: Karl F. Malik, Ph.D., 

Director Division of Extramural Activities, 

National Institutes of Diabetes and Digestive 

and Kidney Diseases, 6707 Democracy Blvd., 

Room 7329, MSC 5452, Bethesda, MD 20892, 

(301) 594–4757, malikk@niddk.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: 

www.niddk.nih.gov/fund/divisions/DEA/ 

Council/coundesc.htm., where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 5, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26073 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; NIDDK RC2 Review. 

Date: December 11, 2024. 

Time: 11:00 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

NIDDK, Democracy II, Suite 7000A, 6707 

Democracy Boulevard, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Thomas A. Tatham, Ph.D., 

Scientific Review Officer, National Institute 

of Diabetes and Digestive and Kidney, 

National Institute of Health, 6707 Democracy 

Boulevard, Rm. 7021, Bethesda, MD 20892– 

5452, (301) 594–3993, tathamt@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: November 5, 2024. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26071 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

NIMH HIV/AIDS Review (P30, R25, T32, 

K99). 

Date: December 11, 2024. 

Time: 11:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Contact Person: Rebecca Steiner Garcia, 

Ph.D., Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd, Bethesda, MD 20892, 

301–443–4525, email: steinerr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.242, Mental Health Research 

Grants, National Institutes of Health, HHS) 

Dated: November 6, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–26139 Filed 11–8–24; 8:45 am] 

BILLING CODE 4140–01–P 


khammond on DSKJM1Z7X2PROD with NOTICES